Original Research

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L

OncoTargets and Therapy 2017, 10:5445-5458

Published Date: 14 November 2017